New drug cocktail targets Hard-to-Treat myeloma spread
NCT ID NCT04166565
First seen May 01, 2026 · Last updated Jun 04, 2026 · Updated 7 times
Summary
This study tests a combination of four drugs (daratumumab, bortezomib, cyclophosphamide, and dexamethasone) in 41 people with multiple myeloma that has spread outside the bones, known as extramedullary disease. The goal is to see how well the treatment works and how safe it is. Participants are either newly diagnosed or have had only one prior treatment, and they are followed for up to 5 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ankara University
Ankara, Turkey (Türkiye)
-
Anticancer Hospital of Thessaloniki
Thessaloniki, Greece
-
Dokuz Eylul University
Balçova, Turkey (Türkiye)
-
Erciyes University
Kayseri, Turkey (Türkiye)
-
Marmara University
Pendik, Turkey (Türkiye)
-
Univerity of Turin
Torino, Italy
-
University of Athens
Athens, Greece
-
University of Bologna
Bologna, Italy
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.